COL5A1, the final gene in our prognostic panel, is upregulated across multiple malignancies, including glioma, clear cell renal cell carcinoma, and gastric cancer (Feng et al., 2019; Gu et al., 2021; Yang et al., 2022). The gene discussed is COL5A1; the disease is central nervous system cancer.